UnitedHealth sues US government over lowered Medicare Advantage star ratings

UnitedHealth Group sued the US government over its 2027 Medicare Advantage star ratings, claiming improper calculations could reduce bonus payments and patient benefits. The company, the largest Medicare Advantage insurer, said ratings for 45 contracts would rise if calculated correctly. CMS declined to comment. Other insurers, including CVS Health, have also sued over their ratings.

Original reporting
Published Nov 20, 2026, 4:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 20, 2026, 4:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UnitedHealth sues US government over lowered Medicare Advantage star ratings — source image
Decision brief

The 30-second read

$UNHBearishMed
01

Why it matters

The legal challenge could affect UnitedHealth's revenue from government bonuses and influence the broader Medicare Advantage market.

02

Market read

The filing introduces regulatory risk for UnitedHealth and may affect investor sentiment toward health insurers.

03

What to watch

Potential settlement or policy change could mitigate financial loss; the case may set precedent for other insurers.

Relevance 7/10Novelty 8/10Timing: today

Background

UnitedHealth, the largest Medicare Advantage insurer, alleges CMS used improper measures in star ratings, threatening bonus payments.

Company-level read

Ticker impact

$UNHBearishHigh confidence
Context

UnitedHealth Group filed a lawsuit against CMS over Medicare Advantage star ratings, a new legal action that could affect bonus payments.

Expected impact

likely pressure as the market prices in possible loss of bonus payments and higher costs.

Evidence & confidence

Legal dispute over star ratings could reduce bonus payments worth billions and affect investor sentiment.

Market effects

May raise concerns for other Medicare Advantage insurers and could prompt regulatory scrutiny of star rating methodology.

U.S. health insurance sector could see modest volatility.

Limited to U.S. markets; no direct global impact.

Counterpoint

The lawsuit could force CMS to adjust ratings upward, potentially boosting UnitedHealth's future earnings.

Key entities

  • UnitedHealth Group

    Largest Medicare Advantage insurer filing the lawsuit.

  • Centers for Medicare & Medicaid Services (CMS)

    Agency responsible for star ratings.

Related articles

$UNHMed

UnitedHealth Stock (UNH) Rises After the Healthcare Company Filed a Lawsuit Against the U.S. Government

UnitedHealth (UNH) stock rose 4.61% after filing a lawsuit against the U.S. government over a star rating drop by the Centers for Medicare & Medicaid Services, claiming improper measures were used. The company seeks higher ratings for 45 contracts, potentially increasing them by 0.5 to 1.5 stars. Analyst Ryan Langston upgraded UNH to Buy with a $455 price target, citing strong earnings growth.

$UNHMed

Cowen Upgrades UNH and HUM Stocks to Buy and Lifts Price Targets After Healthcare Sell-Off. Here’s Why

Cowen upgraded UnitedHealth (UNH) and Humana (HUM) to Buy, citing strong earnings growth prospects. Analyst Ryan Langston raised UNH's price target to $455 and HUM's to $485. Both stocks rose in pre-market trading after a healthcare sector sell-off due to proposed CMS regulations. Cowen expects UNH's EPS to grow mid-high teens through 2028 and HUM's to reach $40.42 by 2028.

$UNHMed

UnitedHealth sues to reverse downgraded Medicare Advantage quality scores

UnitedHealth Group sued the U.S. government over lowered Medicare Advantage star ratings for 2027, joining 14 other insurers. The company, the largest Medicare Advantage insurer, claims the ratings calculation is inconsistent and unfairly reduces scores below bonus thresholds. Medicare Advantage plans are rated on a scale of one to five stars, with higher ratings earning bonus payments.

$UNHMed

TD Cowen upgrades UnitedHealth stock rating on earnings outlook

TD Cowen upgraded UnitedHealth Group (UNH) to Buy, raising its price target to $455 from $402. The stock is down 19% in a week. Analysts cite Medicare Advantage, Optum Health, and Commercial/Medicaid improvements for mid-high-teens EPS growth through 2028. UNH reported Q3 2026 EPS of $4.69, beating estimates. Multiple analysts adjusted price targets and earnings estimates.